These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

700 related items for PubMed ID: 8649787

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells.
    Müller S, Miller WH, Dejean A.
    Blood; 1998 Dec 01; 92(11):4308-16. PubMed ID: 9834237
    [Abstract] [Full Text] [Related]

  • 24. Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein.
    Tsuzuki S, Towatari M, Saito H, Enver T.
    Mol Cell Biol; 2000 Sep 01; 20(17):6276-86. PubMed ID: 10938104
    [Abstract] [Full Text] [Related]

  • 25. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation.
    Benoit G, Altucci L, Flexor M, Ruchaud S, Lillehaug J, Raffelsberger W, Gronemeyer H, Lanotte M.
    EMBO J; 1999 Dec 15; 18(24):7011-8. PubMed ID: 10601023
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genistein.
    Ng AP, Nin DS, Fong JH, Venkataraman D, Chen CS, Khan M.
    Mol Cancer Ther; 2007 Aug 15; 6(8):2240-8. PubMed ID: 17699721
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.
    Mologni L, Marchesi E, Nielsen PE, Gambacorti-Passerini C.
    Cancer Res; 2001 Jul 15; 61(14):5468-73. PubMed ID: 11454693
    [Abstract] [Full Text] [Related]

  • 28. The t(15;17) translocation in acute promyelocytic leukemia.
    Lavau C, Jansen J, Dejean A.
    Pathol Biol (Paris); 1995 Mar 15; 43(3):188-96. PubMed ID: 7675545
    [Abstract] [Full Text] [Related]

  • 29. Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression.
    Bruel A, Benoit G, De Nay D, Brown S, Lanotte M.
    Leukemia; 1995 Jul 15; 9(7):1173-84. PubMed ID: 7630193
    [Abstract] [Full Text] [Related]

  • 30. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.
    Grignani F, Testa U, Rogaia D, Ferrucci PF, Samoggia P, Pinto A, Aldinucci D, Gelmetti V, Fagioli M, Alcalay M, Seeler J, Grignani F, Nicoletti I, Peschle C, Pelicci PG.
    EMBO J; 1996 Sep 16; 15(18):4949-58. PubMed ID: 8890168
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
    Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG.
    Nature; 1998 Feb 19; 391(6669):815-8. PubMed ID: 9486655
    [Abstract] [Full Text] [Related]

  • 33. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
    Guidez F, Ivins S, Zhu J, Söderström M, Waxman S, Zelent A.
    Blood; 1998 Apr 15; 91(8):2634-42. PubMed ID: 9531570
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha.
    Gianni' M, Kalaç Y, Ponzanelli I, Rambaldi A, Terao M, Garattini E.
    Blood; 2001 May 15; 97(10):3234-43. PubMed ID: 11342454
    [Abstract] [Full Text] [Related]

  • 38. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D, Solomon E.
    Curr Top Microbiol Immunol; 1997 May 15; 220():81-112. PubMed ID: 9103677
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.